Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3182
Selected: 0
NCT IDTitle
NCT00778375Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
NCT04038619Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
NCT03989466Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
NCT06158139Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT00759603Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
NCT00508456Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
NCT04751422Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine
NCT00059631Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone
NCT00360672Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
NCT00083772Use of Nesiritide in the Management of Acute Diastolic Heart Failure
NCT01902966Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
NCT00508339Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients
NCT01202877PKC412 and 5-Azacytidine
NCT00561912Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
NCT00301028Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
NCT06409065Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
NCT00590902Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
NCT00450125Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection
NCT03214510Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery
NCT01619774An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor
NCT00037882PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron
NCT04169542Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
NCT05773040A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
NCT06575374Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell
NCT00490282A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer
NCT00673179Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
NCT039417692018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II
NCT00382590Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
NCT04220827Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT05017103Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
NCT01627080Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation
NCT07009886Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
NCT00734526Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
NCT00924820A Pilot Study of Bevacizumab for Neoplastic Meningitis
NCT06401603A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
NCT03099850Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
NCT05130580Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction
NCT06522373Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
NCT04296305Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
NCT06397027A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
NCT00941759Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
NCT056743963-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
NCT06722846Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
NCT01365156Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
NCT01224288Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
NCT02282969PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
NCT07153796A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
NCT05062395Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
NCT02815995Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
NCT03541902Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma